down arrow

Gland Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
1,401.40
8.15 (0.58%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
1,384.05
1,405.83
1,401.71
1,537.45
1,545.16
1,373.42
1,208.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,384.05
1,405.83
1,401.71
1,537.45
1,545.16
1,373.42
1,208.69
Raw Material Cost
437.38
485.88
461.65
574.69
464.00
517.92
465.53
Purchase of Finished goods
2.15
2.66
6.58
6.76
6.38
6.13
3.79
(Increase) / Decrease In Stocks
23.18
86.93
96.02
17.94
128.86
-2.49
-16.42
Employee Cost
342.86
329.81
355.53
351.61
345.33
304.95
255.00
Power Cost
54.66
45.38
46.52
57.88
64.04
58.28
49.79
Manufacturing Expenses
0.00
-0.01
0.01
-0.01
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
163.86
158.12
171.01
169.93
180.16
164.56
157.03
Total Expenditure (Excl Depreciation)
1,024.09
1,108.77
1,137.32
1,178.80
1,188.77
1,049.35
914.73
Operating Profit (PBDIT) excl Other Income
359.96
297.06
264.39
358.65
356.39
324.07
293.96
Other Income
58.49
59.66
51.43
42.15
37.39
53.16
37.54
Operating Profit (PBDIT)
418.45
356.72
315.82
400.80
393.78
377.23
331.50
Interest
22.82
6.11
5.62
9.96
5.28
6.05
4.92
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
395.63
350.61
310.20
390.84
388.50
371.18
326.58
Depreciation
96.33
93.83
91.96
92.61
105.34
81.30
65.32
Profit Before Tax
299.30
256.78
218.25
298.23
283.16
289.89
261.27
Tax
94.61
93.25
74.48
105.81
91.30
95.81
67.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
204.69
163.53
143.76
192.42
191.86
194.08
194.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
204.69
163.53
143.76
192.42
191.86
194.08
194.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
204.69
163.53
143.76
192.42
191.86
194.08
194.10
Equity Capital
16.48
16.48
16.48
16.47
16.47
16.47
16.47
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
12.42
9.92
8.72
11.68
11.65
11.78
11.79
Diluted Earnings per share
12.42
9.93
8.73
11.68
11.65
11.78
11.78
Operating Profit Margin (Excl OI)
26.01%
21.13%
18.86%
23.33%
23.06%
23.6%
24.32%
Gross Profit Margin
28.58%
24.94%
22.13%
25.42%
25.14%
27.03%
27.02%
PAT Margin
14.79%
11.63%
10.26%
12.52%
12.42%
14.13%
16.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2024 is -1.55% vs 0.29% in Sep 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2024 is 25.17% vs 13.75% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is 21.17% vs 12.36% in Sep 2024

stock-summary

Interest

QoQ Growth in quarter ended Dec 2024 is 273.49% vs 8.72% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

Compare Quarterly Results Of Gland Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,384.05
3,230.00
-1,845.95
-57.15%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,384.05
3,230.00
-1,845.95
-57.15%
Raw Material Cost
437.38
536.11
-98.73
-18.42%
Purchase of Finished goods
2.15
387.30
-385.15
-99.44%
(Increase) / Decrease In Stocks
23.18
11.81
11.37
96.27%
Employee Cost
342.86
709.71
-366.85
-51.69%
Power Cost
54.66
0.00
54.66
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
163.86
755.27
-591.41
-78.30%
Total Expenditure (Excl Depreciation)
1,024.09
2,400.20
-1,376.11
-57.33%
Operating Profit (PBDIT) excl Other Income
359.96
829.80
-469.84
-56.62%
Other Income
58.49
77.32
-18.83
-24.35%
Operating Profit (PBDIT)
418.45
907.12
-488.67
-53.87%
Interest
22.82
220.93
-198.11
-89.67%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
395.63
686.19
-290.56
-42.34%
Depreciation
96.33
192.30
-95.97
-49.91%
Profit Before Tax
299.30
497.33
-198.03
-39.82%
Tax
94.61
112.81
-18.20
-16.13%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
204.69
381.08
-176.39
-46.29%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
204.69
381.08
-176.39
-46.29%
Share in Profit of Associates
0.00
3.44
-3.44
-100.00%
Minority Interest
0.00
4.29
-4.29
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
204.69
380.23
-175.54
-46.17%
Equity Capital
16.48
40.06
-23.58
-58.86%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.42
9.49
2.93
30.87%
Diluted Earnings per share
12.42
9.44
2.98
31.57%
Operating Profit Margin (Excl OI)
26.01%
25.69%
0.00
0.32%
Gross Profit Margin
28.58%
21.24%
0.00
7.34%
PAT Margin
14.79%
11.90%
0.00
2.89%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,384.05 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -1.55% vs 0.29% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -10.43% vs 64.68% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 204.69 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 25.17% vs 13.75% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 6.69% vs -17.28% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 359.96 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 21.17% vs 12.36% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 1.00% vs 23.08% in Dec 2023

Quarterly - Interest
Interest 22.82 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 273.49% vs 8.72% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 332.20% vs 101.53% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.01%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023